Navigation Links
AHRQ Announces New Members to U.S. Preventive Services Task Force
Date:3/5/2008

titutes of Health and Institute of Medicine committees in these areas. He is a member of the Centers for Medicare & Medicaid Services Medical Care Advisory Committee and the Blue Cross and Blue Shield Association's Medical Advisory Panel.

Dr. Wilt, a board-certified internal medicine specialist, is a professor in the Department of Medicine at the University of Minnesota and the Minneapolis Veteran Affairs Medical Center. As an investigator in the Minneapolis VA Health Services Research and Development Center for Chronic Disease Outcomes Research, his research interests include evidence-based chronic disease prevention and management. Dr. Wilt served on the Outcomes Research & Epidemiology Task Force in 1997 and currently sits on the editorial board of the American Journal of Medicine.

Dr. Melnyk is dean and distinguished foundation professor in nursing at the Arizona State University College of Nursing & Healthcare Innovation. She is a pediatric and psychiatric nurse practitioner whose research focuses on improving mental health outcomes in children, teens, and parents. She directs the National Association of Pediatric Nurse Practitioners' "Keep Your Children/Yourself Safe and Secure" mental health promotion program. She served on the American Academy of Pediatrics Mental Health Task Force in 2006 and the Institute of Medicine's working committee on evidence-based practice in 2007. For her dedication to innovative programming leading to health care solutions, the American Academy of Nursing named her a 2006 Edge Runner.

About the U.S. Preventive Services Task Force

The U.S. Preventive Services Task Force is the leading independent panel of experts in prevention and primary care. The Task Force, which is supported by AHRQ, conducts rigorous, impartial assessments of the scientific evidence for the effectiveness of a broad range of clinical preventive services including screening, counseling, and preventive medications. Its recommenda
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. ADAMS Announces the Addition of Dani Barfield to the Firms Staff as Associate Project Manager
2. Trevena, Inc. Announces $24 Million Series A Financing
3. DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
4. eDiets.com(R) Announces Q4 and Year End 2007 Results
5. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter 2007 Financial Results
6. Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets
7. Smith & Nephew Announces Breakthrough VERILAST(TM) Technology
8. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
9. S.C. BlueCross Announces Second Annual National Walk @ Lunch Day
10. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
11. Shopko Announces New Prototype Store in Council Bluffs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...partment of Defense and Federal Agencies in, the ...olden Phoenix is a, four-day, multi-agency colla...l, state and local agencies with large and complex...ding a vital, ad-hoc, secure mobile communicatio...ise., NORFOLK, Va., July 25 /PRNewswire/ -- Datal...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
(Date:7/25/2008)...ogram delivers immediate cost savings for http://...ss to language interpreters] to firms switching l...s. , Washington, D.C. (V...e-inc.com/index.html [(Language Learning Enterpri... translation, and language instruction services to...
(Date:7/25/2008)...us-based law firm represents Pickerington man who ...olumbus-area Kroger store , ...http://www.donaheyohioinjurylawyers.com [The Dona...law firms in central Ohio, has filed a product lia...08CV9804) against The Kroger Co., in connection wi...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
... between Hewlett Packard and the government in Nor...r prescriptions towards the implementation// of an...lth Social Services and Public Safety has announce...ern Ireland will be equipped with an electronic sy...
...ll have a new medical college from the next academ...ednesday that the proposed medical college will be...n addition to the new campus of the Rajiv Gandhi U... said, "The revenue department will identify alter...
...has revealed that those who drink coffee very rare...heavy drinkers.// According to a study in the Sep...ple could get a heart attack within one hour of ha...k of almost 60% amongst moderate coffee drinkers, ...
..."Pascal" Norris, who died in July, is thought to b...an two decades in Scotland. NHS Borders revealed t...ied on 8 July in Edinburgh Royal Infirmary and lat...died of anthrax. Health Protection Scotland said ...
Other Medicine News:
(Date:7/23/2008)... Protein Therapeutics that Modulate Alte...Mass., July 23 /- Taligen Therapeutic...e growth plan with the,appointment of Abbie Celnik...blishment of its headquarters in Cambridge, Mass. ...ounder of the company who remains president., Und...
(Date:7/22/2008)...ent Initiative bring MJFF,s,current active industr...2009, NEW YORK, July 22 /PRNewswire-USNewswire/ -...sformative treatments and a cure for Parkinson,s,d...n,s Research has awarded,$2.7 million in total fun...re granted under MJFF,s Therapeutics Development I...
(Date:7/22/2008)...a(R) Resulted in Significant, Reductions in A1C in...ithm Used, BRIDG... the "Adjust to,Target in Type 2 Diabetes: Compari... for Adjustment of Mealtime Insulin Glulisine" stu...ation,s (ADA) medical journal,Diabetes Care. This...
(Date:7/22/2008)...ersity Medical Center Based on Rosetta G...st Differentiates Squamous From Non-Squamous Non-S...us-Cell Carcinoma of the Lung With Sensitiv...is is the First CLIA Approved Test Which Leverages... Accurate Diagnosis of Lung Cancer, REHOVOT, Isra...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Hip replacement improves function saves money at any age 21969 1Hip replacement improves function saves money at any age 21969 2LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 1LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 2Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 1Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 2Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 1Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 2
... patients taking,once-daily Lialda remained relaps...May 22, 2007 /PRNewswire-FirstCall/ -- A,long-term... (303),presented at the British Society of Gastroe...rch 2007 showed Shire plc,s,Lialda(mesalamine) is ...day, secondary endpoints of study 303 were present...
... Doses, According to,New Data Presented at Digesti...wswire/ -- UCB announced today that,new data prese...ated long-term response and remission in Crohn,s d...pegol), the only Fc-free,PEGylated, Fab, fragment ... long-term open label,continuation of the Phase II...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5
Delicate curved shafts with light crisscross serrations. Serrated handle with polished finish. Most popular size or model.
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model.
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish.
Straight tubular shaft with delicate 1.5 mm oval jaws. Squeeze barrel style handle with tip guard and polished finish.
Medicine Products: